SCHEMBL24398702

SCHEMBL24398702

Cc1noc(C)c1-c1cc([N+](=O)[O-])ccc1OCCO

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
TSHR P16473 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
PTGDR2 Q9Y5Y4 1/20 0.46
AKR1C3 P42330 3/20 0.45
BRD4 O60885 3/20 0.42
CREBBP Q92793 1/20 0.41
ALDH1A1 P00352 2/20 0.40
PDE5A O76074 2/20 0.40
S1PR4 O95977 1/20 0.40
ERN1 O75460 1/20 0.40
GABRA5 P31644 1/20 0.39
CYP19A1 P11511 2/20 0.39
CYP11B1 P15538 2/20 0.39
CYP11B2 P19099 2/20 0.39
MAPT P10636 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29619095 1.00 MEN1 (0.46) MEN1KMT2ATSHRTDP1PTGDR2
SCHEMBL16619017 0.84 AKR1C3 (0.47) MEN1KMT2ATDP1PTGDR2AKR1C3
SCHEMBL1903461 0.83 TDP1 (0.48) TDP1AKR1C3BRD4ALDH1A1CYP19A1
SCHEMBL29619010 0.83 MAPT (0.46) MEN1KMT2ATDP1AKR1C3BRD4
SCHEMBL29619121 0.82 ALDH1A1 (0.43) MEN1KMT2AAKR1C3BRD4ALDH1A1
SCHEMBL17467704 0.82 AKR1C3 (0.41) MEN1KMT2ATSHRTDP1AKR1C3
SCHEMBL29619013 0.81 BRD4 (0.48) KMT2ABRD4CREBBPALDH1A1MAPT
SCHEMBL29619075 0.80 BRD4 (0.45) PTGDR2BRD4CREBBP
SCHEMBL16618869 0.78 TDP1 (0.48) MEN1KMT2ATSHRTDP1AKR1C3
SCHEMBL11980663 0.78 ALDH1A1 (0.49) MEN1KMT2ATSHRTDP1BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022093850-A1 ISOXAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2022-05-05 WO disclosed